Status:
COMPLETED
Development and Application of Intelligent Assessment System of Longshi Scale
Lead Sponsor:
Shenzhen Second People's Hospital
Conditions:
Stroke
Disability Physical
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study was to verify convenience and feasibility of the novel intelligent Longshi assessment system to provide an accurate and convenient evaluation tool for stroke survivors.
Eligibility Criteria
Inclusion
- Stroke survivors
- age≥18 years
- diagnosis of cerebral infraction or intracerebral hemorrhage
- stable vital signs
- willingness to participate in the study with informed consent
- Professional evaluators:
- One to ten years of working experience
- experience in rehabilitation scientific research or education related work for more than two years
- association with Longshi Scale research
- Non-professional evaluators：
- the family or caregiver of stroke survivors
- ability to read and communicate
- willingness to participate in the study with informed consent
Exclusion
- Stroke survivors:
- brain tumor, Parkinson's disease or active epilepsy within past three months
- impaired cognitive functions
- participation in any other clinical study
- Professional evaluators:
- refusal to participate in the study
- Non-professional evaluators:
- care for patients with serious mental health problems
- refusal to participate in the study
Key Trial Info
Start Date :
September 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT05214638
Start Date
September 10 2021
End Date
December 31 2021
Last Update
January 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China